| Carrie Ng, MD | |
|
1405 Clifton Rd Ne, Atlanta, GA 30322-1060 | |
| (404) 785-7141 | |
| (404) 785-7989 |
| Full Name | Carrie Ng |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Emergency Medicine |
| Location | 1405 Clifton Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003108309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0204X | Pediatrics - Pediatric Emergency Medicine | 89564 (Georgia) | Primary |
| Entity Name | Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
Women may be known as the more talkative sex, but when it comes to a certain sensitive health topic, their lips are sealed, according to a new "Bladder Talk" survey of 780 women aged 35 and older in North America (U.S. and Canada) sponsored by TENA(R), the worldwide leader in the management of bladder protection, and conducted by Harris Interactive.
University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.
In the wake of recent disappointments over clinical trials targeting amyloid plaque build-up in Alzheimer's disease, researchers are focusing more attention on misfolded tau protein, another culprit in brain diseases that cause dementia.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
Marketing exclusivity periods for first-in-class drugs have fallen dramatically in recent decades - from a median of 10.2 years in the 1970s to 2.5 years in the early part of this decade - underscoring the competitive nature of drug development, a new study recently completed by the Tufts Center for the Study of Drug Development has found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie Ng, MD 1405 Clifton Rd Ne, Atlanta, GA 30322-1060 Ph: (404) 785-7141 | Carrie Ng, MD 1405 Clifton Rd Ne, Atlanta, GA 30322-1060 Ph: (404) 785-7141 |
News Archive
Women may be known as the more talkative sex, but when it comes to a certain sensitive health topic, their lips are sealed, according to a new "Bladder Talk" survey of 780 women aged 35 and older in North America (U.S. and Canada) sponsored by TENA(R), the worldwide leader in the management of bladder protection, and conducted by Harris Interactive.
University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.
In the wake of recent disappointments over clinical trials targeting amyloid plaque build-up in Alzheimer's disease, researchers are focusing more attention on misfolded tau protein, another culprit in brain diseases that cause dementia.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
Marketing exclusivity periods for first-in-class drugs have fallen dramatically in recent decades - from a median of 10.2 years in the 1970s to 2.5 years in the early part of this decade - underscoring the competitive nature of drug development, a new study recently completed by the Tufts Center for the Study of Drug Development has found.
› Verified 9 days ago
Dr. Seth Benjamin Marcus, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 993-d Johnson Ferry Rd Ne Suite 440, Atlanta, GA 30342 Phone: 404-257-0799 | |
Dr. Bharath Srivatsa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5901 Peachtree Dunwoody Rd Ne, Suite B 420, Atlanta, GA 30328 Phone: 404-252-9751 Fax: 678-990-5763 | |
Michael Mallory, MD, MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 1001 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-250-2972 | |
Briana Cary Patterson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2015 Uppergate Dr, Atlanta, GA 30322 Phone: 404-727-6721 | |
Evan Orenstein, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1405 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-785-6104 Fax: 404-785-1462 | |
Andrew John Galway Mcreynolds, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 49 Jesse Hill Jr Dr Se, Pediatrics Residency Training Program, Atlanta, GA 30303 Phone: 404-778-1440 |